Market growth can be attributed to increasing demand for analytical services for biologics and large-molecule drugs, increasing biopharmaceutical pipeline, increasing approvals for biopharmaceuticals, increasing number of biosimilar clinical trials, increasing number of R&D. On the other hand, during the forecast period, pricing pressures faced by major players and a shortage of skilled professionals are expected to curb the overall market growth to some extent.